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  One of the anabolic steroid hormones， Primobolan Depot， was administered to the patients
who were on the maintenance hemodialysis due to chronic renal insuthciency． The dosage was
200mg or 400 mg per week． The following results were obtained．
  1． Blood transfusion required to maintain our standard （RBC 2 x 106， Hb 45 ％， Ht 18N20 ％）
was less than in the control group． These hematological parameters changed much less and
became rather stab｝e in the administered group．
  2． Slight elevation of tl e serum protein and A／G ratio were observed in the admini’b’tered
group．
  3． The steroid did not give infiuence on the serum level of electrolytes， urea nitrogen and
creatinine．
  4． Bone marrow study always showed suppression of the function in these patients． The
anabolic steroid hormone was proved to improve erythropoiesis．
  5． lt was concluded that administration of anabolic steroid hormone associated with food
protein of 1 g per kg body weight would give a good result to the patients．
  6． As to side reactions， amenorrhea， acne vulgaris and hirsutisrn were seen in a few cases，
but no liver damage was proved in any case．
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～3．4mEq／L， Clは 102～112 mEq／しの域にあっ
た．
Table 2．透析液の組成
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研 究 方 法
 1）透析方法
 使用した人工腎装置はSweden Freezer社製home
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Figl 2．赤血球数の変化（200 mg／週硬投与群）
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 Fig．13， A／G比の変化（対照群）
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Fig．17．透析前後の血清Kの変化
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プリモボラン量 200 mg／wk 400 mg／wk 400 mg／wk 400 mg／wk
投与の前後 前 後 前 後 前 後 前 後
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